articles
王磊
2019, 43(8): 0-0.
中文摘要:美国生物盾牌计划自2004年开始实施以来,对于生物安全领域的新一代疫苗和药物等医学应对措施的研发、生产和储备起到了重要推动作用,有效提升了美国生物安全能力。2019年7月,美国政府宣布加强部署生物盾牌计划。本文从计划的提出、计划的主要内容、计划的研发策略以及主要研究成果等方面介绍了美国生物盾牌计划的基本情况,总结了美国实施生物盾牌计划的成功经验,并根据生物盾牌计划主管部门负责人的论述分析了美国生物盾牌计划的未来发展方向,以期为我国生物安全科技创新及应对能力建设提供有益借鉴。
关键词:生物盾牌计划,生物安全,医学应对措施
The U.S. government strengthened deployment of Project BioShield.
WANG lei1*, ZHANG xueyan1, WANG zhongxia2
1 Academy of Military Medical Science, Beijing 100850
2 The Fifth Medical Center,Chinese PLA General Hospital ,Beijing 100071
*corresponding author, Tel: 010-66931146, E-mail: wangleienjoy@163.com
ABSTRACT:Since its implementation in 2004,the US Project BioShield has played an important role in the development, production and stockpiling of new generation vaccines, drugs and other medical countermeasures in the field of Biosafety & Biosecurity, effectively enhancing the U.S. capacity. In July 2019, the U.S. government announced plans to strengthen deployment of Project BioShield. This paper introduces Project BioShield from the aspects of the proposal, the main contents, the research and development strategy, and the main outcomes of the project. Based on the analysis and discussion of the head of department in charge of Project BioShield, the paper also summarizes the successful experience of its implementation and analyzes its future development direction, in the hope of providing useful reference for China’s biosafety technology innovation and response capacity building.
KEYWORDS:Project BioShield ,Biosafety & Biosecurity, Medical Countermeasures (MCM)